Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy.

Khandekar D, Amara S, Tiriveedhi V.

Front Oncol. 2019 Apr 25;9:315. doi: 10.3389/fonc.2019.00315. eCollection 2019. Review.

2.

Oligodeoxynucleotides ODN 2006 and M362 Exert Potent Adjuvant Effect through TLR-9/-6 Synergy to Exaggerate Mammaglobin-A Peptide Specific Cytotoxic CD8+T Lymphocyte Responses against Breast Cancer Cells.

Babaer D, Amara S, McAdory BS, Johnson O, Myles EL, Zent R, Rathmell JC, Tiriveedhi V.

Cancers (Basel). 2019 May 14;11(5). pii: E672. doi: 10.3390/cancers11050672.

3.

Impact of Precision Medicine on Drug Repositioning and Pricing: A Too Small to Thrive Crisis.

Tiriveedhi V.

J Pers Med. 2018 Nov 5;8(4). pii: E36. doi: 10.3390/jpm8040036. Review.

4.

High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx.

Babaer D, Amara S, Ivy M, Zhao Y, Lammers PE, Titze JM, Tiriveedhi V.

Oncotarget. 2018 May 18;9(38):25193-25205. doi: 10.18632/oncotarget.25391. eCollection 2018 May 18.

5.

Potential anticancer effect of prostratin through SIK3 inhibition.

Alotaibi D, Amara S, Johnson TL, Tiriveedhi V.

Oncol Lett. 2018 Mar;15(3):3252-3258. doi: 10.3892/ol.2017.7674. Epub 2017 Dec 20.

6.

Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.

Amara S, Majors C, Roy B, Hill S, Rose KL, Myles EL, Tiriveedhi V.

PLoS One. 2017 Jun 28;12(6):e0180097. doi: 10.1371/journal.pone.0180097. eCollection 2017.

7.

Inflammatory role of high salt level in tumor microenvironment (Review).

Amara S, Tiriveedhi V.

Int J Oncol. 2017 May;50(5):1477-1481. doi: 10.3892/ijo.2017.3936. Epub 2017 Mar 27. Review.

PMID:
28350105
8.

The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.

Amara S, Tiriveedhi V.

Int J Mol Sci. 2017 Mar 17;18(3). pii: E650. doi: 10.3390/ijms18030650. Review.

9.
10.

Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells.

Amara S, Zheng M, Tiriveedhi V.

Cell Biochem Biophys. 2016 Sep;74(3):427-34. doi: 10.1007/s12013-016-0736-7. Epub 2016 May 28.

11.

High salt induces anti-inflammatory MΦ2-like phenotype in peripheral macrophages.

Amara S, Whalen M, Tiriveedhi V.

Biochem Biophys Rep. 2016 Sep;7:1-9.

12.

Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists.

Nirogi R, Shinde A, Tiriveedhi V, Kota L, Saraf SK, Badange RK, Mohammed AR, Subramanian R, Muddana N, Bhyrapuneni G, Abraham R.

Eur J Med Chem. 2016 Jan 27;108:655-662. doi: 10.1016/j.ejmech.2015.12.005. Epub 2015 Dec 10.

PMID:
26731168
13.

Sodium channel γENaC mediates IL-17 synergized high salt induced inflammatory stress in breast cancer cells.

Amara S, Ivy MT, Myles EL, Tiriveedhi V.

Cell Immunol. 2016 Apr;302:1-10. doi: 10.1016/j.cellimm.2015.12.007. Epub 2015 Dec 19.

14.

Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis.

Amara S, Lopez K, Banan B, Brown SK, Whalen M, Myles E, Ivy MT, Johnson T, Schey KL, Tiriveedhi V.

Mol Immunol. 2015 Mar;64(1):26-35. doi: 10.1016/j.molimm.2014.10.021. Epub 2014 Nov 11.

15.

Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.

Tiriveedhi V, Tucker N, Herndon J, Li L, Sturmoski M, Ellis M, Ma C, Naughton M, Lockhart AC, Gao F, Fleming T, Goedegebuure P, Mohanakumar T, Gillanders WE.

Clin Cancer Res. 2014 Dec 1;20(23):5964-75. doi: 10.1158/1078-0432.CCR-14-0059.

16.

Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis.

Platt D, Amara S, Mehta T, Vercuyssee K, Myles EL, Johnson T, Tiriveedhi V.

Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):107-12.

17.

Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.

Soysal SD, Muenst S, Kan-Mitchell J, Huarte E, Zhang X, Wilkinson-Ryan I, Fleming T, Tiriveedhi V, Mohanakumar T, Li L, Herndon J, Oertli D, Goedegebuure SP, Gillanders WE.

Breast Cancer Res Treat. 2014 Oct;147(3):527-37. doi: 10.1007/s10549-014-3129-x. Epub 2014 Sep 12.

18.

Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.

Baskaran G, Tiriveedhi V, Ramachandran S, Aloush A, Grossman B, Hachem R, Mohanakumar T.

J Heart Lung Transplant. 2014 Sep;33(9):950-6. doi: 10.1016/j.healun.2014.04.020. Epub 2014 May 9.

19.

Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.

Sarma NJ, Tiriveedhi V, Crippin JS, Chapman WC, Mohanakumar T.

J Virol. 2014 Apr;88(7):3733-43. doi: 10.1128/JVI.03060-13. Epub 2014 Jan 15.

20.

Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy.

Angaswamy N, Klein C, Tiriveedhi V, Gaut J, Anwar S, Rossi A, Phelan D, Wellen JR, Shenoy S, Chapman WC, Mohanakumar T.

Am J Transplant. 2014 Mar;14(3):685-93. doi: 10.1111/ajt.12592. Epub 2014 Jan 10.

21.

Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression.

Tiriveedhi V, Upadhya GA, Busch RA, Gunter KL, Dines JN, Knolhoff BL, Jia J, Sarma NJ, Ramachandran S, Anderson CD, Mohanakumar T, Chapman WC.

Transpl Immunol. 2014 Mar;30(2-3):93-8. doi: 10.1016/j.trim.2013.12.003. Epub 2013 Dec 29.

PMID:
24380732
22.

Role of defensins in the pathogenesis of chronic lung allograft rejection.

Tiriveedhi V, Banan B, Deepti S, Nataraju A, Hachem R, Trulock E, Alexander PG, Thalachallour M.

Hum Immunol. 2014 Apr;75(4):370-7. doi: 10.1016/j.humimm.2013.12.014. Epub 2013 Dec 28.

23.

Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.

Angaswamy N, Tiriveedhi V, Banan B, Benshoff N, Chapman W, Mohanakumar T.

Transpl Immunol. 2013 Dec;29(1-4):64-70. doi: 10.1016/j.trim.2013.09.002. Epub 2013 Sep 12.

PMID:
24036218
24.

Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Angaswamy N, Tiriveedhi V, Sarma NJ, Subramanian V, Klein C, Wellen J, Shenoy S, Chapman WC, Mohanakumar T.

Hum Immunol. 2013 Nov;74(11):1478-85. doi: 10.1016/j.humimm.2013.07.002. Epub 2013 Jul 19. Review.

25.

Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.

Tiriveedhi V, Gautam B, Sarma NJ, Askar M, Budev M, Aloush A, Hachem R, Trulock E, Myers B, Patterson AG, Mohanakumar T.

J Heart Lung Transplant. 2013 Aug;32(8):807-14. doi: 10.1016/j.healun.2013.06.003.

26.
27.

Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens.

Tiriveedhi V, Takenaka M, Sarma NJ, Gelman AG, Mohanakumar T.

J Heart Lung Transplant. 2013 Jul;32(7):714-22. doi: 10.1016/j.healun.2013.04.006. Epub 2013 May 2.

28.

Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.

Basha HI, Ramachandran S, Tiriveedhi V, Takenaka M, Subramanian V, Nath DS, Benshoff N, Patterson GA, Mohanakumar T.

Transplantation. 2013 Jan 27;95(2):293-300. doi: 10.1097/TP.0b013e3182772244.

29.

Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway.

Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T.

PLoS One. 2012;7(11):e50826. doi: 10.1371/journal.pone.0050826. Epub 2012 Nov 30.

30.

Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.

Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M.

Bioorg Med Chem Lett. 2012 Dec 15;22(24):7431-5. doi: 10.1016/j.bmcl.2012.10.057. Epub 2012 Oct 17.

PMID:
23141912
31.

Modulation of immune responses following solid organ transplantation by microRNA.

Sarma NJ, Tiriveedhi V, Ramachandran S, Crippin J, Chapman W, Mohanakumar T.

Exp Mol Pathol. 2012 Dec;93(3):378-85. doi: 10.1016/j.yexmp.2012.09.020. Epub 2012 Oct 1. Review.

32.

Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.

Takenaka M, Subramanian V, Tiriveedhi V, Phelan D, Hachem R, Trulock E, Gelman AE, Patterson GA, Hoshinaga K, Mohanakumar T.

J Heart Lung Transplant. 2012 Nov;31(11):1214-22. doi: 10.1016/j.healun.2012.08.011. Epub 2012 Sep 11.

33.

The role of molecular chaperonins in warm ischemia and reperfusion injury in the steatotic liver: a proteomic study.

Tiriveedhi V, Conzen KD, Liaw-Conlin J, Upadhya G, Malone J, Townsend RR, Kerns R, Jia J, Csontos K, Ramachandran S, Mohanakumar T, Anderson CD, Chapman WC.

BMC Biochem. 2012 Sep 10;13:17.

34.

Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.

Takenaka M, Tiriveedhi V, Subramanian V, Hoshinaga K, Patterson AG, Mohanakumar T.

PLoS One. 2012;7(8):e42370. doi: 10.1371/journal.pone.0042370. Epub 2012 Aug 10.

35.

T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.

Tiriveedhi V, Takenaka M, Ramachandran S, Gelman AE, Subramanian V, Patterson GA, Mohanakumar T.

Am J Transplant. 2012 Oct;12(10):2663-74. doi: 10.1111/j.1600-6143.2012.04191.x. Epub 2012 Jul 23.

36.

Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.

Sarma NJ, Tiriveedhi V, Angaswamy N, Mohanakumar T.

Hum Immunol. 2012 Dec;73(12):1275-81. doi: 10.1016/j.humimm.2012.06.014. Epub 2012 Jul 10. Review.

37.

Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells.

Tiriveedhi V, Fleming TP, Goedegebuure PS, Naughton M, Ma C, Lockhart C, Gao F, Gillanders WE, Mohanakumar T.

Breast Cancer Res Treat. 2013 Feb;138(1):109-18. doi: 10.1007/s10549-012-2110-9. Epub 2012 Jun 8.

38.

Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.

Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T.

Am J Transplant. 2012 Aug;12(8):2164-71. doi: 10.1111/j.1600-6143.2012.04079.x. Epub 2012 May 8.

39.

An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection.

Tiriveedhi V, Sarma N, Mohanakumar T.

Int J Immunogenet. 2012 Oct;39(5):373-80. doi: 10.1111/j.1744-313X.2012.01112.x. Epub 2012 Apr 10. Review.

40.

LMP-420, a small molecular inhibitor of TNF-α, prolongs islet allograft survival by induction of suppressor of cytokine signaling-1: synergistic effect with cyclosporin-A.

Angaswamy N, Fukami N, Tiriveedhi V, Cianciolo GJ, Mohanakumar T.

Cell Transplant. 2012;21(6):1285-96. doi: 10.3727/096368911X637371. Epub 2012 Mar 27.

PMID:
22469483
41.

Autonomous transmembrane segment S4 of the voltage sensor domain partitions into the lipid membrane.

Tiriveedhi V, Miller M, Butko P, Li M.

Biochim Biophys Acta. 2012 Jul;1818(7):1698-705.

42.

Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17.

Weber J, Tiriveedhi V, Takenaka M, Lu W, Hachem R, Trulock E, Patterson GA, Mohanakumar T.

J Heart Lung Transplant. 2012 Apr;31(4):419-26. doi: 10.1016/j.healun.2011.12.012. Epub 2012 Jan 29.

43.

HIF-1α signaling by airway epithelial cell K-α1-tubulin: role in fibrosis and chronic rejection of human lung allografts.

Tiriveedhi V, Gelman AE, Mohanakumar T.

Cell Immunol. 2012;273(1):59-66. doi: 10.1016/j.cellimm.2011.11.006. Epub 2011 Dec 4.

44.

A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.

Tiriveedhi V, Angaswamy N, Brand D, Weber J, Gelman AG, Hachem R, Trulock EP, Meyers B, Patterson G, Mohanakumar T.

Clin Exp Immunol. 2012 Jan;167(1):158-68. doi: 10.1111/j.1365-2249.2011.04486.x.

45.

Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.

Tiriveedhi V, Sarma NJ, Subramanian V, Fleming TP, Gillanders WE, Mohanakumar T.

Hum Immunol. 2012 Jan;73(1):11-6. doi: 10.1016/j.humimm.2011.10.017. Epub 2011 Oct 23.

46.

Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD.

Transplantation. 2011 Dec 15;92(11):1259-68. doi: 10.1097/TP.0b013e318235a1ab.

47.

Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.

Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T.

J Heart Lung Transplant. 2011 Jun;30(6):624-31. doi: 10.1016/j.healun.2011.01.708. Epub 2011 Mar 16.

48.

A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.

Nath DS, Tiriveedhi V, Basha HI, Phelan D, Moazami N, Ewald GA, Mohanakumar T.

Transplantation. 2011 May 15;91(9):1036-43. doi: 10.1097/TP.0b013e318211d2f4.

49.

Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.

Anderson CD, Upadhya G, Conzen KD, Jia J, Brunt EM, Tiriveedhi V, Xie Y, Ramachandran S, Mohanakumar T, Davidson NO, Chapman WC.

Liver Transpl. 2011 Feb;17(2):189-200. doi: 10.1002/lt.22220.

50.

Kinetic analysis of the interaction between poly(amidoamine) dendrimers and model lipid membranes.

Tiriveedhi V, Kitchens KM, Nevels KJ, Ghandehari H, Butko P.

Biochim Biophys Acta. 2011 Jan;1808(1):209-18. doi: 10.1016/j.bbamem.2010.08.017. Epub 2010 Sep 7.

Supplemental Content

Loading ...
Support Center